These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8730728)

  • 21. The role of late I and antiarrhythmic drugs in EAD formation and termination in Purkinje fibers.
    Fedida D; Orth PM; Hesketh JC; Ezrin AM
    J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1():S71-S78. PubMed ID: 16686685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium.
    Davidenko JM; Cohen L; Goodrow R; Antzelevitch C
    Circulation; 1989 Mar; 79(3):674-86. PubMed ID: 2917391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the rabbit Purkinje fibre assay as an in vitro tool for assessing the risk of drug-induced torsades de pointes in humans.
    Aubert M; Osterwalder R; Wagner B; Parrilla I; Cavero I; Doessegger L; Ertel EA
    Drug Saf; 2006; 29(3):237-54. PubMed ID: 16524323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.
    Ducroq J; Printemps R; Guilbot S; Gardette J; Salvetat C; Le Grand M
    J Pharmacol Toxicol Methods; 2007; 56(2):159-70. PubMed ID: 17604185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiological and arrhythmogenic effects of the histamine type 1-receptor antagonist astemizole on rabbit Purkinje fibers: clinical relevance.
    Adamantidis MM; Lacroix DL; Caron JF; Dupuis BA
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):319-27. PubMed ID: 7475058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiarrhythmic and electrophysiological effects of the novel KATP channel opener, rilmakalim, in rabbit cardiac cells.
    Riccioppo Neto F; Mesquita Júnior O; Olivera GB
    Gen Pharmacol; 1997 Aug; 29(2):201-5. PubMed ID: 9251899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pirmenol, a new antiarrhythmic drug with potassium- and sodium-channel blocking activity; a voltage-clamp study in rabbit Purkinje fibres.
    Reichardt B; Konzen G; Hauswirth O
    Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):462-71. PubMed ID: 2164163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence.
    Barrett TD; Hennan JK; Fischbach PS; O'Neill BP; Driscoll EM; Lucchesi BR
    Br J Pharmacol; 2001 Apr; 132(7):1493-500. PubMed ID: 11264243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional effects of the late sodium current inhibition by AZD7009 and lidocaine in rabbit isolated atrial and ventricular tissue and Purkinje fibre.
    Persson F; Andersson B; Duker G; Jacobson I; Carlsson L
    Eur J Pharmacol; 2007 Mar; 558(1-3):133-43. PubMed ID: 17198698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiologic effects of propafenone on canine ischemic cardiac cells.
    Zeiler RH; Gough WB; El-Sherif N
    Am J Cardiol; 1984 Aug; 54(3):424-9. PubMed ID: 6465028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electropharmacological effects of berberine on canine cardiac Purkinje fibres and ventricular muscle and atrial muscle of the rabbit.
    Riccioppo Neto F
    Br J Pharmacol; 1993 Feb; 108(2):534-7. PubMed ID: 8448600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The isolated rabbit heart and Purkinje fibers as models for identifying proarrhythmic liability.
    Roche M; Renauleaud C; Ballet V; Doubovetzky M; Guillon JM
    J Pharmacol Toxicol Methods; 2010; 61(3):238-50. PubMed ID: 20117224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle.
    Brown BS
    J Pharmacol Exp Ther; 1989 Feb; 248(2):552-8. PubMed ID: 2918472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological effects of tiracizin and its metabolites in dog cardiac Purkinje fibers.
    Németh M; Varró A; Papp JG
    Gen Pharmacol; 1995 Jul; 26(4):793-8. PubMed ID: 7635254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of torsades de pointes in rabbit ventricles perfused with sedating and nonsedating histamine H1-receptor antagonists.
    Gilbert JD; Cahill SA; McCartney DG; Lukas A; Gross GJ
    Can J Physiol Pharmacol; 2000 May; 78(5):407-14. PubMed ID: 10841436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
    Bottino D; Penland RC; stamps A; Traebert M; Dumotier B; Georgiva A; Helmlinger G; Lett GS
    Prog Biophys Mol Biol; 2006; 90(1-3):414-43. PubMed ID: 16321428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of erythromycin-induced early afterdepolarizations and torsade de pointes ventricular tachycardia by mexiletine.
    Fazekas T; Krassói I; Lengyel C; Varró A; Papp JG
    Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 2):147-50. PubMed ID: 9474662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of new antiarrhythmic agent SS-68 on excitation conduction, electrical activity in Purkinje fibers and pulmonary veins: Assessment of safety and side effects risk.
    Bogus SK; Kuzmin VS; Abramochkin DV; Suzdalev KF; Galenko-Yaroshevsky PA
    J Pharmacol Sci; 2017 Mar; 133(3):122-129. PubMed ID: 28325557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potassium channel openers antagonize the effects of class III antiarrhythmic agents in canine Purkinje fiber action potentials. Implications for prevention of proarrhythmia induced by class III agents.
    Kondo M; Tsutsumi T; Mashima S
    Jpn Heart J; 1999 Sep; 40(5):609-19. PubMed ID: 10888381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inotropic and electrophysiological effects of AB--2, a new antiarrhythmic agent, on isolated cardiac preparations.
    Beresewicz A; Pytkowski B; Sedek G; Zdanowski K
    Pol J Pharmacol Pharm; 1983; 35(3):223-32. PubMed ID: 6651921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.